• Information

LPixel Presents at EDGE-NEXT Tokyo Symposium

LPixel Inc., a leader in image analysis and processing technology in life science and medical research, is pleased to announce that its members from the Medical Business Department, Hikari Oguma and Mariko Takahashi presented at this year’s Exploration and Development of Global Entrepreneurship for NEXT Generation (EDGE-NEXT) Tokyo Symposium 2018. Sponsored by the Ministry of Education, Culture, Sports, Science in Technology (MEXT), this program aims to promote the start of new businesses and help Japanese university startups develop strategies to enter the US market. In August, participating teams took part in a comprehensive training program that took place in San Diego, California. During the symposium, held on March 14, 2019, Oguma and Takahashi gave a presentation on their accomplishments. Through this program, LPixel was able to conduct market research and engage with a potential joint research partner in the US.

【State of the stage】

【Projection slide ※ part】

About LPixel
Founded in March 2014, LPixel is a University of Tokyo spin-off that hones its expertise in life science image analysis. LPixel unifies artificial intelligence and its image analysis technologies to develop and provide advanced software for researchers and professionals in the life science industry, including the medical, pharmaceutical and agricultural sectors. LPixel is currently working in collaboration with the University of Tokyo, the National Cancer Center Japan and other research institutions to further the development of its AI-powered medical diagnosis technology. For more information, please visit


Cutting-Edge Technologies that Lead Future Medical Diagnosis
EIRL analyzes a wide range of medical data to provide an accurate and efficient diagnosis. EIRL aims to be the closest partner to all doctors, and serve as another powerful set of eyes to provide top quality medical care.
AI Accelerating
Phase R&D
IMACEL, an image analysis AI, helps to solve various issues in the drug discovery process.
Life science and AI experts support successful AI implementation.



Alphabetical listing


A Third Career Option for Researchers